soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Reduces Events in People with Type 2 Oral Semaglutide and Cardiovascular Outcomes

Preventing diabetic kidney disease progression: an update It is important to implement treatments to delay and prevent diabetic kidney disease progression by aiming for tight metabolic and blood pressure control and simultaneously addressing cardiovascular risk factors aggressively

Glucose Regulation Studies: Investigated for its effects on glucose pathways, including insulin secretion and regulation in metabolic dysregulation models

Leitsalu, L

Yamamoto H, Lee CE, Marcus JN, Williams TD, Michael Overton J, Lopez ME, et al

Optimizing protein intake is the most important intervention to preserve muscle mass during weight loss

adequate fluid intake helps manage constipation, a frequent adverse effect of GLP-1 drugs